Tags: Allergies | ragwitek | ragweed | allergy | merck

Help For Ragweed Allergy

Thursday, 17 Apr 2014 04:02 PM

The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek.

The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis.

The approval for Ragwitek comes days after U.S. regulatory approval for Merck's grass pollen allergy drug Grastek.

Merck's Ragwitek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
FDA-Approved-Drugs
The U.S. Food and Drug Administration has approved Merck Co's pollen allergy drug Ragwitek. The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis. The approval for Ragwitek comes days after U.S....
ragwitek, ragweed, allergy, merck
77
2014-02-17
Thursday, 17 Apr 2014 04:02 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved